For managers of COVID-19 in India, the next few days will be crucial. The backdrop of rising cases—5,274 as on April 8—has only added to the policymakers’ dilemma of extending the lockdown and handling the situation on the ground, given India’s unique medical, economic, social and psychological challenges.
Experts are closely following the movement of the epidemiological curve of COVID-19, but they say that it is still “too early” to comment on whether the curve had “peaked” or flattened yet. “The cases we are seeing now are of people who acquired the infection prior to the lockdown,” says Dr. Tarun Bhatnagar, epidemiologist, Indian Council of Medical Research-National Institute of Epidemiology. Data from the coming week would also be crucial in deciding on the lifting of restrictions. “The spike from one big cluster may not indicate a national trend,” says Bhatnagar, who is also a member of the national task force for COVID-19. “Besides, we would also need to analyse whether these primary cases have resulted in secondary and tertiary transmission, and if so, what is the extent of those cases.”
Dr. Giridhar R. Babu, professor, and head, life course epidemiology, Public Health Foundation of India, says that the “real curve” will be understood only when India follows a “syndrome-based” surveillance for COVID-19 throughout the country and expands testing. This approach implies that all cases of fever, cough, malaise and any other respiratory symptoms must be treated as COVID-19 unless proved otherwise, and home isolation of patients must be ensured.
This story is from the April 19, 2020 edition of THE WEEK.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the April 19, 2020 edition of THE WEEK.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Between hospital and home
Transitional care centres can add a lot to India's health care system
EFFORT VS EFFECT
The government's attempts to ensure quality drugs is evident, but how well new policies can be monitored on the ground remains to be seen
A way to let go of fear
Accepting the use of adult diapers is a journey with various stages-denial, concealment, rejection and reluctance
Mandeeps & a miracle
Two strangers, one deadly disease and an act of kindness. How Mandeep Mann saved Mandeep Singh, an acute leukaemia patient, by donating his stem cells
The A, B, C of cosmetic surgery
Between eight to 10 lakh cosmetic surgeries happen in India every year. Who is an ideal candidate, and what are the risks and results you can expect?
Vaccines and meningitis
In sub-Saharan Africa, from Senegal in the west to Ethiopia in the east, and encompassing the northern part of Nigeria, there exists a region known as the African Meningitis Belt (AMB).
Celebrating diversity and inclusivity
As Indians battle it out in our nation's 18th general election, it is again time for voters to reflect on the \"Idea of India\"-or rather, on two duelling ideas of India that are now before us and between which the nation must choose at the ballot box.
Defendant: an Hermès handbag
When Hermès was hit with a class-action lawsuit last month for \"antitrust\" activities, it didn't see it coming. Most of the luxury world has all eyes on this suit, filed by two interested consumers who claim they were denied a purchase, and whether it would go to trial.
A legacy, bound
Amal Allana's biography of her father, Ebrahim Alkazi, is as much personal as it is historical
Cutting-edge chronicle
In his new book, Salman Rushdie's pen is mightier than the knife